Silver Standard Resources Price Target Cut to $17.00 (SSRI)
Silver Standard Resources (NASDAQ: SSRI) had its price target lowered by RBC Capital from $20.00 to $17.00 in a research note released on Tuesday morning.
Shares of Silver Standard Resources traded up 1.01% during mid-day trading on Tuesday, hitting $10.04. Silver Standard Resources has a one year low of $9.24 and a one year high of $16.92. The stock’s 50-day moving average is currently $11.49. The company has a market cap of $810.7 million and a P/E ratio of 14.64.
A number of other analysts have also recently weighed in on SSRI. Analysts at Scotiabank reiterated a sector perform rating on shares of Silver Standard Resources in a research note to investors on Monday, February 25th. Separately, analysts at Zacks downgraded shares of Silver Standard Resources from an outperform rating to a neutral rating in a research note to investors on Tuesday, February 5th. They now have a $14.70 price target on the stock. Finally, analysts at Deutsche Bank downgraded shares of Silver Standard Resources from a hold rating to a sell rating in a research note to investors on Tuesday, January 15th. They now have a $12.50 price target on the stock, down previously from $15.00.
Five equities research analysts have rated the stock with a buy rating, four have assigned a hold rating, and one has issued a sell rating to the company. Silver Standard Resources presently has an average rating of overweight and a consensus target price of $19.62.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

SSRI seems to be a good long play, will likely hit $50 in the next 4-5 years. From current prices that’s $4 profit for every dollar spent. Say you put in 10,000 and forget about it… if it does hit 50, you get 40,000 pure profit. And if there is a crash from now to then, it bounces back quick, within 4 months in the 2008-09 crash… that’s faster than most stocks. If Cyprus banking shakes up the market, try SSRI. Even if you cash out at $18, which it may see within 3-5 months, you can’t go wrong.